News

One in three addicts suffer from post-traumatic stress disorder (PTSD). To ensure that addicts reap lasting treatment benefits, it's often necessary to treat them for underlying traumas as well, according to a doctoral research study conducted by psychologist Nele Gielen who obtained her PhD from Maastricht University on 29 April 2016. 

One in three addicts suffer from post-traumatic stress disorder (PTSD). To ensure that addicts reap lasting treatment benefits, it's often necessary to treat them for underlying traumas as well...

MaCSBio's director of education Bert Smeets has been interviewed for the Dutch serie: 'Research Loont' (translation: 'Research pays off') about the unraveling of genetic causes of hereditary metabolic disease among children.

"A BREXIT? Political, financial and legal aspects"
A forum about the UK Brexit referendum of 23 June 2016.

Effective 1 May, Jan Cobbenhagen will be the new Chief Executive Officer of the Brightlands Maastricht Health Campus (BL MHC). 

Effective 1 May, Jan Cobbenhagen will be the new Chief Executive Officer of the Brightlands Maastricht Health Campus (BL MHC).  

Professor Philippe Lambin of Maastricht UMC+ and the Maastro Clinic has been awarded a prestigious Advanced Grant by the European Research Council (ERC).

‘Our excessive individualism is at the root of the unwillingness to solve environmental problems.

Researchers at the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University have developed a smarter method for growing human tissues in laboratories. This method cleverly stimulates the natural self-organising capacity of stem cells to form complex tissues.

If COPD can be detected at an earlier stage in healthy people, this can improve treatment and may lead to lower direct health care costs. COPD is an insidious disease; you feel nothing until part of your lung function is lost. The disease is predicted to become the third leading cause of death in Europe by 2020.